Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
698.25
-14.62 (-2.05%)
At close: May 15, 2026, 4:00 PM EDT
697.16
-1.09 (-0.16%)
After-hours: May 15, 2026, 7:51 PM EDT
Regeneron Pharmaceuticals Analyst Ratings
Total Analysts
23
Consensus Rating
Buy
Price Target
$842.13
Upside
+20.61%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $975 → $995 | Strong Buy | Maintains | $975 → $995 | +42.50% | May 1, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $779 → $762 | Hold | Maintains | $779 → $762 | +9.13% | Apr 30, 2026 |
| Barclays | Barclays | Buy Maintains $923 → $917 | Buy | Maintains | $923 → $917 | +31.33% | Apr 30, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $801 → $796 | Strong Buy | Maintains | $801 → $796 | +14.00% | Apr 30, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $825 → $800 | Hold | Maintains | $825 → $800 | +14.57% | Apr 30, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $880 → $960 | Strong Buy | Maintains | $880 → $960 | +37.49% | Apr 23, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $800 | Buy | Reiterates | $800 | +14.57% | Apr 23, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $769 → $796 | Hold | Maintains | $769 → $796 | +14.00% | Apr 10, 2026 |
| Bernstein | Bernstein | Buy Maintains $925 → $921 | Buy | Maintains | $925 → $921 | +31.90% | Apr 8, 2026 |
| Piper Sandler | Piper Sandler | Buy Initiates $875 | Buy | Initiates | $875 | +25.31% | Mar 31, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $818 → $801 | Strong Buy | Maintains | $818 → $801 | +14.72% | Mar 31, 2026 |
| Barclays | Barclays | Buy Initiates $923 | Buy | Initiates | $923 | +32.19% | Mar 6, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $745 → $765 | Hold | Maintains | $745 → $765 | +9.56% | Mar 2, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $865 → $975 | Strong Buy | Maintains | $865 → $975 | +39.63% | Feb 9, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $850 → $950 | Buy | Maintains | $850 → $950 | +36.05% | Feb 2, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $750 → $865 | Buy | Reiterates | $750 → $865 | +23.88% | Feb 2, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.